Our new service “N-NOSE plus Pancreas” has been featured in over 150 media worldwide.
Some of them are listed below
・REUTERS(UK)
・Daily Mail Online(UK)
・franceinfo(France)
・consalud(Spain)
・INTERESTING ENGINEERING(USA)
・新浪网(China)
・South China Morning Post(Hong Kong)
・GMA News(The Philippines)
・ABP News(India)
・The Indian practitioner(India)
・harjha24( UAE)
We aim to commercialize more cancer-specific tests.
We as HIROTSU Bio Science Inc. (Head Office: Chiyoda-ku, Tokyo; Representative: Takaaki Hirotsu (Hereinafter referred to as “HIROTSU”) are pleas . . .
2024.04.01On March 18, 2024, an reveiw articles on cancer screening by a third-party research team (Romania) was published in "Cancers", an oncology journ . . .
2024.03.29HIROTSU Bioscience Inc. (Head Office: Chiyoda-ku, Tokyo, Representative: Takaaki Hirotsu, hereinafter referred to as “HIROTSU) has verified the . . .
2024.02.29